Chevy Chase’s Blue Energy raised $380M to prefab shipyard‑built nuclear plants and says the first 1.5GW Texas project could start construction in Q3 2026 with a gas‑to‑nuclear plan.

London-based Synthesia is opening a downtown Austin office and expects dozens of hires by year end as it scales U.S. operations. The move follows a major funding round.

The European Commission authorized Moderna’s mCOMBRIAX for adults 50+, giving the Cambridge company a key commercial win while U.S. approval remains unsettled.

Google's AI Overviews are surfacing the City of San Diego's Inside San Diego posts above local reporting, prompting concern that official messaging could overshadow independent journalism.

A private, invite-only Endless Frontiers retreat in Austin brought Trump and Biden-era officials, top CEOs and backers together to map U.S. tech and national-security strategy.

UF researchers at the Whitney Lab in St. Augustine are mapping how sea stars regrow tissue, revealing gene programs that could inform future human regenerative medicine.

A Michoud‑built section of NASA’s SLS rolled out Monday in New Orleans and will head by barge to Kennedy Space Center as crews prep final assembly for Artemis III.

Eagle Nuclear says the Aurora site near McDermitt, Oregon contains roughly 37 million pounds of uranium and has begun permitting and drilling planning.

A new White House budget proposal would slash NASA science funding and could force program cancellations and more layoffs at Pasadena’s Jet Propulsion Laboratory.

A UC San Diego analysis of ABCD data finds teen cannabis use tied to smaller gains in memory, attention and processing speed. Researchers say THC exposure, not CBD, may drive the effect.

Utah lawmakers approved H.B. 218 and H.B. 273 to add AI literacy to K–12, restrict K–3 device use and fund Convergence Hall, pairing classroom changes with big teacher training.

Eli Lilly is reportedly in advanced talks to buy Boston‑based Kelonia Therapeutics for more than $2 billion, folding a promising in‑vivo CAR‑T program into Lilly’s pipeline.

Sunnyvale‑based Cerebras filed an S‑1 showing big 2025 growth, a major OpenAI compute partnership and new data‑center expansion as it aims to list as CBRS.